Please login to the form below

Not currently logged in

Sonia Ruiz Moran appointed president of EMVO

She joins the verification organisation from the General Pharmaceutical Council of Spain

European Medicines Verification Organisation (EMVO) Sonia Ruiz MoranThe European Medicines Verification Organisation (EMVO) has appointed Sonia Ruiz Moran as its new president, replacing John Chave, former secretary general of Pharmaceutical Group of the European Union (PGEU).

She comes to the EMVO with a wealth of pharma experience, having led European Public Affairs at the General Pharmaceutical Council of Spain, since 2008.

This saw her head up the Council's Brussel's office, providing strategic advice in EU regulatory affairs, together with advocacy on initiatives with an impact on health issues.

Prior to joining the General Pharmaceutical Council of Spain, Ruiz Moran worked at Prisa, a leading education and entertainment-focused media holding company in Spanish-speaking countries.

She said: “The planning and design of a pan-European medicine verification system has been very complex. I believe that our mission now is about helping stakeholders in Member States to implement national verification systems that function at an equal level of efficacy, are interoperable and cost effective, in order to prevent falsified medicines from reaching patients, in accordance with EU legislation.”

Set up in February by a group of European trade associations that includes EFPIA and its counterparts in generics, biosimilars and wholesalers, the EMVO is based in Luxembourg.

21st July 2015

From: Regulatory



Featured jobs

Subscribe to our email news alerts


Add my company

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...